Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?

BACKGROUND: The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings. METHODS: We retrospectively reviewed 436 patients with pT1-3N0-2M0 RCC w...

Descripción completa

Detalles Bibliográficos
Autores principales: Taguchi, Satoru, Buti, Sebastiano, Fukuhara, Hiroshi, Otsuka, Masafumi, Bersanelli, Melissa, Morikawa, Teppei, Miyazaki, Hideyo, Nakagawa, Tohru, Fujimura, Tetsuya, Kume, Haruki, Igawa, Yasuhiko, Homma, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328261/
https://www.ncbi.nlm.nih.gov/pubmed/28241027
http://dx.doi.org/10.1371/journal.pone.0172341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328261/
https://www.ncbi.nlm.nih.gov/pubmed/28241027
http://dx.doi.org/10.1371/journal.pone.0172341

Ejemplares similares